Authors
Shevchenko Yu.L.1, Borshchev G.G.1, Katkov A.A.1, Zainiddinov F.A.1, Sidorov R.V.2, Omarov A.I.1
1 Pirogov National Medical and Surgical Center, Moscow
2 Rostov State Medical University, Rostov-on-Don
Abstract
The basic principle of minimally invasive cardiac surgery is to minimize surgical trauma, reduce blood loss, achieve a cosmetic outcome, and lower the risk of infection. As a result, patients recover more quickly and their quality of life improves.
Despite this, coronary artery bypass grafting through a median sternotomy remains the gold standard for coronary revascularization surgery. This is due to the technical approach of minithoracotomy and its method’s reproducibility. The indications for minimally invasive coronary bypass grafting are the same as those for traditional sternotomy.
In some patients, coronary angiography reveals a coronary bed that is unsuitable for surgical revascularization. Furthermore, ongoing medical conservative treatment does not lead to expected success and is therefore ineffective. In these cases, we use the minimally invasive hybrid technique of extracardiac myocardial vascularization, known as “YurLeon”. With this approach, we first perform stenting on the necessary and accessible segment of the coronary artery. Next, we perform the YurLeon procedure through a minithoracotomy, which stimulates extracardiac vascularization of the heart.
This treatment method for CAD (coronary artery disease) is safe and effective, with good early clinical outcomes. It does not require extensive training, making it a reproducible and valuable option for coronary revascularization.
Keywords: еxtracardiac myocardial vascularization, hybrid myocardial revascularization, minimally invasive coronary artery bypass grafting.
References
1. Rogers CA, Pike K, Angelini GD, Reeves BC, Glauber M, Ferrarini M, Murphy GJ. An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: the Sternotomy Versus Thoracotomy (STET) trial. J Thorac Cardiovasc Surg. 2013; 146(2): 306-16.e1-9. doi: 10.1016/j.jtcvs.2012.04.020.
2. Une D, Sakaguchi T. Initiation and modification of minimally invasive coronary artery bypass grafting. Gen Thorac Cardiovasc Surg. 2019; 67(4): 349-354. doi: 10.1007/s11748-018-1050-7.
3. Nambiar P, Kumar S, Mittal CM, Saksena K. Minimally invasive coronary artery bypass grafting with bilateral internal thoracic arteries: Will this be the future? J Thorac Cardiovasc Surg. 2018; 155(1): 190-197. doi: 10.1016/ j.jtcvs.2017.07.088.
4. Kikuchi K, Chen X, Mori M, Kurata A, Tao L. Perioperative outcomes of off-pump minimally invasive coronary artery bypass grafting with bilateral internal thoracic arteries under direct vision†. Interact Cardiovasc Thorac Surg. 2017; 24(5): 696-701. doi: 10.1093/icvts/ivw431.
5. Raja SG, Garg S, Rochon M, Daley S, De Robertis F, Bahrami T. Short-term clinical outcomes and long-term survival of minimally invasive direct coronary artery bypass grafting. Ann Cardiothorac Surg. 2018; 7(5): 621-627. doi: 10.21037/acs.2018.06.14.
6. Shevchenko YuL, Simonenko VB, Borshchev GG. Extracardial revascularization of the myocardium in diffuse lesions of the coronary bed, as a component of complex treatment of patients with coronary heart disease. Klinicheskaya medicina. 2018; 96(11): 10–18. (In Russ.)
7. Shevchenko YuL, Borshchev GG. Extracardial myocardial revascularization in patients with coronary artery disease with diffuse coronary disease. М.: Pirogov National Medical and Surgical Center, 2022. (In Russ.)
8. Borshchev GG. Extravascular myocardial revascularization in complex treatment of patients with coronary artery disease: historical background and current realities. Medicinskij vestnik Yuga Rossii. 2015; 2: 4-8. (In Russ.) doi: 10.21886/2219-8075- 2015-2-4-8.
9. Gąsior M, Zembala MO, Tajstra M, Filipiak K, Gierlotka M, Hrapkowicz T, Hawranek M, Poloński L, Zembala M; POL-MIDES (HYBRID) Study Investigators. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv. 2014; 7(11): 1277-83. doi: 10.1016/j.jcin. 2014.05.025.
10. Patel NC, Hemli JM, Seetharam K, Singh VP, Scheinerman SJ, Pirelli L, Brinster DR, Kim MC. Minimally invasive coronary bypass versus percutaneous coronary intervention for isolated complex stenosis of the left anterior descending coronary artery. J Thorac Cardiovasc Surg. 2022; 163(5): 1839-1846.e1. doi: 10.1016/j.jtcvs.2020.04.171.
